Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Endo Pharmaceuticals Inc. v. Perrigo UK FINCO Limited Partnership
Case Number:
1:19-cv-00437
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
August 20, 2019
Endo, Perrigo Strike Deal In Nasal Spray Patent Suit
Endo Pharmaceuticals and Perrigo UK Finaco Ltd. Partnership told a Delaware federal court Tuesday they have reached a settlement to end allegations that Perrigo infringed patents covering Endo's vitamin B12 nasal spray, Nascobal.
-
March 05, 2019
Endo Wants Perrigo's B12 Nasal Spray Generic Blocked
Endo Pharmaceuticals Inc. has accused Perrigo UK Finco Ltd. Partnership in Delaware federal court of infringing patents covering its vitamin B12 nasal spray Nascobal by applying to make a generic version of the medicine.